Brief: First Participant Imaged In Phase Ii Sar-Bombesin Prostate Cancer Trial In The US
06/10/2022 14:18
Oct 6 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX :
* FIRST PARTICIPANT IMAGED IN PHASE II SAR-BOMBESIN PROSTATE
CANCER TRIAL IN THE US
Source text for Eikon: ID:nPn7JZk2Ta
Further company coverage: CU6.AX
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial